HPV screening with different ways to check for cervical problems
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests two cervical screening approaches to find early signs of HPV-related changes. It may help by improving how results are sorted into “needs follow-up” versus “routine care,” especially for women with different HPV patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to read and understand the study and agree to join by signing consent
- If you’re HIV-negative: age 30–49; if you’re HIV-positive: age 25–49
- You must not be pregnant at the time of screening
- You must not have had a hysterectomy (uterus removed)
- You must not already have cervical cancer or cancer symptoms like abnormal vaginal bleeding or a known pelvic mass
- You should be able to have the exam and follow study visits; serious medical problems that make participation unsafe may exclude you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different ways to screen for HPV (a virus linked to cervical cancer) in women living with HIV. The goal is to find the best, most practical screening approach to catch cervical problems early.
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
This study looks at whether testing for HPV (the virus that can lead to cervical cancer) using a urine sample can help with cervical cancer screening. It’s for women living with HIV, who may be at higher risk and need effective, easy screening.
This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.
This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.
This study aims to make cervical cancer screening easier and more accessible for women living with HIV. Researchers will test new ways to help women get screened and receive follow-up care at three clinics across the United States.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.